UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
기사
(전체 135건)
제목보기
제목보기
제목+내용
기사보기
‘High-value medical devices marketable without sufficient clinical grounds’
The government is seekin...
Park Gi-taek
|
2018-09-06 15:58
기사보기
‘We know Korean genes best’
A Korean authority in genetic medicine estab...
Park Gi-taek
|
2018-07-24 14:42
기사보기
Orders for original drugs spike amid ban of Chinese valsartan
With the government’s ba...
Park Gi-taek
|
2018-07-10 16:03
기사보기
Edwards Lifesciences leads heart valves market
A heart surgeon needs lo...
Park Gi-taek
|
2018-06-26 15:53
기사보기
NHIS head slams health ministry’s incompetence
The head of the state-ru...
Park Gi-taek
|
2018-06-22 15:43
기사보기
Will 3 N. Korean doctors visit Seoul this year?
North Korean physicians ...
Park Gi-taek
|
2018-06-18 15:20
기사보기
Lipiodol excluded from shortage prevention drugs
The Korean health author...
Park Gi-taek
|
2018-06-11 11:30
기사보기
‘Bone formation best to prevent osteoporotic fractures’
Osteoporosis is rapidly ...
Park Gi-taek
|
2018-06-07 16:06
기사보기
‘Biosimilars are better than originals’
“Biosimilars offer bette...
Park Gi-taek
|
2018-05-16 15:56
기사보기
Will Deloitte’s prediction of clinical success work?
“We have developed the w...
Park Gi-taek
|
2018-05-03 13:12
기사보기
Gastric cancer drug Cyramza to get insurance benefit
Eli Lilly’s Cyramza (ing...
Park Gi-taek
|
2018-04-25 11:11
기사보기
Obesity guidelines set anew in 3 stages
The Korean Society for t...
Park Gi-taek
|
2018-04-11 16:45
-
1
2
3
4
5
6
7
8
9
10
다음
-
Back to Top